Company: PGEN
Filing Date: 2025-08-19
Form Type: S-3
Source: 0000950103-25-010472
Chunk: 34

Company: PRECIGEN, INC.
Filing Date: 2025-08-19
Form: S-3
Chunk 34
---
13,520,789 shares of Common Stock held by Kapital Joe,      
 LLC, 3,944,437 shares of Common Stock held by MGK 2009, LLC, 3,703,398 shares of Common Stock held by JPK 2009, LLC, 1,654,363 shares      
 of Common Stock held by JPK 2012, LLC, 1,637,040 shares of Common Stock held by MGK 2011, LLC, 1,096,686 shares of Common Stock held by    
 Parkview 2020, 578,079 shares of Common Stock held by ZSK 2008, LLC, 490,401 shares of Common Stock held by JPK 2008, LLC, 489,438 shares  
 of Common Stock held by MGK 2008, LLC, 453,731 shares of Common Stock held by Kellie L. Banks (2009) Long Term Trust, 351,120 shares of    
 Common Stock held by ZSK 2009, LLC, and 1,403 shares of Common Stock held by Lotus Capital (2000) Co., Inc. Also includes 1,144,481 shares 
 of Common Stock held by Alana D. Kirk, Mr. Kirk’s spouse.                                                                                  |

(5) Information is based on the Schedule
13F that was filed with the SEC on August 13, 2025 by Patient Capital Management, LLC, the Schedule 13F that was filed with the SEC on
August 14, 2025 by Iridian Asset Management, and certain other information known to us.

Relationships with the Selling Stockholders

Underwritten Public Offering

In August 2024, we completed an underwritten public
offering of 39.88 million shares of our Common Stock for net proceeds of $30.9 million. An affiliate of Mr. Kirk, RJ Kirk Trust, purchased
23.5 million shares of Common Stock at the public offering price of $0.85 for an aggregate purchase price of approximately $19.99 million.

Sales of Unregistered Securities

In December 2024, we announced that we had entered
into a Securities Purchase Agreement and a related Registration Rights Agreement with the selling stockholders for the sale of our Preferred
Stock and Warrants to purchase 52.67 million shares of our Common Stock, at an exercise price of $0.75 per share in a private placement.
We sold an aggregate of 79,000 shares